Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research. (April 2020)

• Record Type: Journal Article
• Authors: Inselman, Amy; Liu, Fang; Wang, Cheng; Shi, Qiang; Pang, Li; Mattes, William; White, Matthew; Lyn-Cook, Beverly; Rosas-Hernandez, Hector; Cuevas, Elvis; Lantz, Susan; Imam, Syed; Ali, Syed; Petibone, Dayton M.; Shemansky, Jennifer M.; Xiong, Rui; Wang, Yiying; Tripathi, Priya; Cao, Xuefei; Heflich, Robert H.; Slikker, William
• Is Part Of: Toxicology in vitro. Volume 64(2020)
• Publication Date: 2020-04
• Subjects: Toxicity testing -- In vitro -- Periodicals; Toxicology -- Periodicals; 615.9
• DOI: 10.1016/j.tiv.2019.03.003
• Languages: English
• ISSNs: 0887-2333

Abstract

Abstract: For the past five years, Dr. Daniel Acosta has served as the Deputy Director of Research at the National Center for Toxicological Research (NCTR), a principle research laboratory of the U.S. Food and Drug Administration (FDA). Over his career at NCTR, Dr. Acosta has had a major impact on developing and promoting the use of in vitro assays in regulatory toxicity and product safety assessments. As Dr. Acosta nears his retirement we have dedicated this paper to his many accomplishments at the NCTR. Described within this paper are some of the in vitro studies that have been conducted under Dr. Acosta's leadership. These studies include toxicological assessments involving developmental effects, and the development and application of in vitro reproductive, heart, liver, neurological and airway cell and tissue models. Highlights: Dr. Daniel Acosta directed research at the National Center for Toxicological Research. His long experience benefited research projects involving in vitro biological systems. Research projects use stem cells, organoid and organotypic models. Brain, liver, airway, testicular and developmental toxicity are studied.